FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted

July 13, 2022 -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news